iSpecimen Inc. Reports Board Changes and Shareholder Votes

Ticker: ISPC · Form: 8-K · Filed: 2024-07-22T00:00:00.000Z

Sentiment: neutral

Topics: board-changes, shareholder-vote, officer-compensation

TL;DR

iSpecimen board shake-up, shareholder votes on tap.

AI Summary

On July 17, 2024, iSpecimen Inc. announced changes to its board of directors, including the election of new directors and the departure of existing ones. The company also reported on compensatory arrangements for certain officers and submitted matters to a vote of security holders. Specific details regarding the individuals involved and the outcomes of the votes were not provided in this initial filing.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, while shareholder votes directly impact corporate decision-making and shareholder rights.

Risk Assessment

Risk Level: medium — Board changes and shareholder votes can introduce uncertainty and potential shifts in company direction.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the departure and election of directors, but does not name the individuals involved or the specific changes made in this report.

What compensatory arrangements for certain officers are being reported?

The filing states that compensatory arrangements for certain officers are being reported, but the details of these arrangements are not provided in this document.

What matters were submitted to a vote of security holders?

The filing confirms that matters were submitted to a vote of security holders, but the specific proposals or resolutions are not detailed here.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this filing occurred on July 17, 2024.

Where are iSpecimen Inc.'s principal executive offices located?

iSpecimen Inc.'s principal executive offices are located at 450 Bedford Street, Lexington, MA 02420.

From the Filing

0001104659-24-081547.txt : 20240722 0001104659-24-081547.hdr.sgml : 20240722 20240722171038 ACCESSION NUMBER: 0001104659-24-081547 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240717 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241132213 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2419923d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-07-17 2024-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): July 17, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   450 Bedford Street Lexington , MA 02420 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On July 17, 2024, iSpecimen Inc. (the “Company”) received a written notice from Andrew L. Ross that he will be resigning as a director of

View on Read The Filing